The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

Hyderabad: The National Company Law Tribunal has sanctioned the scheme of amalgamation between contract development and ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up ...

Carbogen Amcis has been granted a GMP certificate for its 9,500m² Saint-Beauzire facility, supporting a wide range of ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...

Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 ...

SINGAPORE] Boustead Singapore’s engineering and construction business unit, under its real estate solutions division Boustead ...

Marcel Botha, CEO of 10XBeta, discusses shortcomings in the US's emergency plans for rapid innovation and manufacturing ...

With its active pharmaceutical ingredient (API) facility “in a state of disrepair,” manufacturer Aspen Biopharma Labs’ operations have ground to a halt in the U.S., according to a recent FDA reprim | ...